Liposomal Bupivacaine for Postoperative Pain Control in Urologic Procedures

Completed · Phase 4

Conditions studied: Urinary Tract Diseases

In brief

A prospective, randomized controlled study to determine the efficacy of liposomal bupivacaine given by local injection at all the wound sites in patients undergoing urologic surgeries.

Key facts

Study ID

NCT02805504

Run by

Loma Linda University

People needed

136

Starts

2016-07-11

Expected to finish

2022-05-09

Last updated by the study team

2024-04-24

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients undergoing urologic surgery.

You may not qualify if…

• Pregnant and/or nursing mothers.
• Allergy to bupivacaine.
• History of drug/alcohol abuse.
• Severe cardiovascular, hepatic, renal disease or neurological impairment.

Where it is running

• Loma Linda Medical Center — Loma Linda, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.